Hepanova, Inc. is a pharmaceutical company established in California USA in 2014 with the mission to discover, develop and commercialize innovative therapeutics for chronic liver diseases with our pipeline targeting NAFLD/NASH, liver fibrosis, hepatitis C, hepatitis B and hepatocellular carcinoma (HCC).
| Website | http://www.hepanova.com |
| Revenue | $1 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2014 |
| Address | 401 Professional Dr Ste 108, Gaithersburg, Maryland 20879, US |
| Phone | +1 240-702-0066 |
| Technologies |
JavaScript
,
HTML
,
PHP
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Hospitals & Clinics, Healthcare |
| Competitors | Roche, Novartis, Pfizer, AstraZeneca, Bristol Myers Squibb, Regeneron, Gilead Sciences, Biogen, Moderna Therapeutics, Lilly India +40 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 801 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 621 Companies |
Looking for a particular Hepanova, Inc. employee's phone or email?
The Hepanova, Inc. annual revenue was $1 million in 2026.
Q. Li is the President and CEO of Hepanova, Inc..
2 people are employed at Hepanova, Inc..
Hepanova, Inc. is based in Gaithersburg, Maryland.
The NAICS codes for Hepanova, Inc. are [62, 621].
The SIC codes for Hepanova, Inc. are [80, 801].